Ercc1 and other markers for stratification of non-small cell lung cancer patients
A non-small cell lung cancer, patient technology, applied in biological testing, analytical materials, instruments, etc., can solve problems such as lack of survival
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0032] Clinical data and biomarker data from 150 patients in the TASTE trial (IFCT-0801TASTE) were received in excel format, saved in .txt format, and read into R language for data preprocessing and statistical analysis. Down figure 1 A flow chart detailing the patients available for the primary and secondary analyzes of ERCC1 association with recurrence-free survival (PFS) and overall survival (OS) and an exploratory analysis assessing the association between various biomarkers is shown picture. ERCC1 proteome data were obtained from FFPE biopsy samples subjected to laser microdissection to obtain tumor tissue and subsequently subjected to selected reaction monitoring mass spectrometry.
[0033] The input proteomic biomarker data were converted to numerical variables, where "ND" representing the non-detectable level of a given biomarker was taken as 0 and "NR" representing missing data was replaced with NA. Survival endpoints were defined according to the STEEP system. Ove...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com